Skip to main content
Premium Trial:

Request an Annual Quote

Swift Biosciences' TP53 Panel

Swift Biosciences has launched an early access program for its next-generation sequencing-based TP53 Panel that covers all coding exons of the gene. The panel uses Swift's Accel-NGS Amplicon Panel technology and runs on Illumina's sequencing instruments. In addition, it is planning another panel using the Accel-NGS Amplicon technology that will target over 200 clinically relevant cancer mutations.